Company: WHWK
Filing Date: 2025-01-21
Form Type: PREM14A
Source: 0001193125-25-009599
Chunk: 98

Company: Whitehawk Therapeutics, Inc.
Filing Date: 2025-01-21
Form: PREM14A
Chunk 98
---
 to make any specific determination as to whether any particular factor, or any aspect of any particular factor, was favorable or unfavorable to the ultimate determination of Aadi’s board of directors. Rather, the recommendation of Aadi’s board of directors was based on the totality of information presented to it and the investigation conducted by it. In considering the factors discussed above, individual directors may have given different weights to different factors. Portions of this explanation of the reasons for the Divestiture and other information presented in this section are forward-looking in nature and, therefore, should be read in light of the section entitled “ Special Note Regarding Forward-Looking Statements.” - 62 -

Opinion of Leerink Partners LLC Introduction Aadi retained Leerink Partners as its financial advisor in connection with the Divestiture contemplated by the Divestiture Agreement. In connection with this engagement, Aadi’s board of directors requested that Leerink Partners evaluate the fairness, from a financial point of view, to Aadi of the consideration proposed to be paid to Aadi pursuant to the terms of the Divestiture Agreement. On December 19, 2024, Leerink Partners rendered to Aadi’s board of directors its oral opinion, which was subsequently confirmed by delivery of a written opinion dated December 19, 2024, that, as of such date and based upon and subject to the various assumptions made, and the qualifications and limitations upon the review undertaken by Leerink Partners in preparing its opinion, the consideration proposed to be paid to Aadi pursuant to the terms of the Divestiture Agreement was fair, from a financial point of view, to Aadi. The full text of the written opinion of Leerink Partners, dated December 19, 2024, which describes the assumptions made and the qualifications and limitations upon the review undertaken by Leerink Partners in preparing its opinion, is attached as Annex C to this proxy statement and is incorporated herein by reference. The summary of the written opinion of Leerink Partners set forth below is qualified in its entirety by the full text of the written opinion attached hereto as Annex C. Leerink Partners’ financial advisory services and opinion were provided for the information and assistance of Aadi’s board of directors (in their capacity as directors and not in any other capacity) in connection with and for purposes of Aadi’s board of directors’ consideration of the Divestiture and the opinion of Leerink Partners addressed only the fairness, from a financial point of view, as of the date thereof, to Aadi of the consideration proposed to